Table 2. Laboratory, angiographic, echocardiographic findings and treatment modalities of AMI patients.

Characteristics	Values
Laboratory findings
Initial CK-MB (ng/mL)	31.5±62.0
Peak CK-MB (ng/mL)	143.7±165.0
Initial Troponin-T (ng/mL)	1.0±2.3
Peak Troponin-T (ng/mL)	1.7±3.1
NT-proBNP (pg/mL)	4676.1±9475.3
Culprit artery
Left main	1 (0.8%)
LAD	50 (41.6%)
LCx	14 (11.7%)
RCA	46 (38.3%)
Angiography not done	9 (7.5%)
Echocardiographic data
LVEF (%)	47.3±13.0
LVEDD (mm)	51.4±6.1
LVESD (mm)	38.1±7.4
LV mass index (g/m2)	106.0±26.6
LA Vol. index (ml/m2)	28.9±11.6
Types of treatment
PCI	96 (80%)
CABG	7 (5.8%)
Medical treatment only	17 (14.2%)
Types of medication
Aspirin	119 (99.2%)
Clopidogrel	114 (95.0%)
ACEi/ARB	102 (85.0%)
Beta-blocker	104 (86.7%)
Spironolactone	20 (16.7%)
CCB	23 (19.2%)
Statin	114 (95%)

Values are presented as a %, or mean ± SD; CK-MB, creatine kinase MB; NT-proBNP, N-terminal pro-brain natriuretic peptide; LAD, left anterior descending artery; LCx, left circumflex artery; RCA, right coronary artery; LVEF, left ventricular ejection fraction; LVEDD, left ventricular end diastolic dimension; LVESD, left ventricular end systolic dimension; LV mass index, left ventricular mass index; LA Vol. index, left atrial volume index; PCI, percutaneous coronary intervention; CABG, coronary artery bypass graft; ACEi, angiotensin converting enzyme inhibitor; ARB, angiotensin receptor blockade; CCB, calcium channel blocker.